WSJ Tech News Briefing: TNB Tech Minute — Nasdaq-100 Will Allow Fast Entry for Large Companies Like SpaceX and OpenAI

Date: March 30, 2026
Host: Danny Lewis, The Wall Street Journal

Episode Overview

In this TNB Tech Minute, Danny Lewis delivers key updates on recent changes in the Nasdaq-100 index, a multi-billion dollar AI drug discovery partnership between Eli Lilly and Insilico, and General Motors’ ramp-up of heavy-duty truck production. The episode highlights how these developments signal industry shifts in tech, pharmaceuticals, and manufacturing.

Key Discussion Points and Insights

1. Nasdaq-100 Index Fast Entry Policy

• Summary:
  Starting May 1st, Nasdaq will allow select listed companies to quickly enter the marquee Nasdaq-100 index, upending the previous year-long waiting period.
• Drivers Behind the Change:
  • Prompted by bankers’ outreach to index providers, looking to accelerate access for hot startups such as OpenAI, Anthropic, and SpaceX.
• Rationale Behind Waiting Periods:
  • Historically enforced to ensure company stability and share liquidity, preparing businesses for increased trading volumes after index inclusion.
• Significance of Inclusion:
  • Companies joining the index gain access to significant retail and institutional capital, as investment funds tracking the index must purchase their shares.
• Quote:

  “Starting May 1st, NASDAQ listed companies will have the chance to quickly join its marquee NASDAQ 100 index instead of waiting up to a year.”
  — Danny Lewis (00:22)

2. Eli Lilly and Insilico’s AI-Driven Drug Partnership

• Summary:
  Pharmaceutical giant Eli Lilly partners with Hong Kong-based Insilico to manufacture drugs discovered using AI.
• Deal Structure:
  • Upfront payment of $115 million to Insilico.
  • Milestone payments could raise the value up to $2.75 billion, plus "tiered royalties on future sales."
• Scope:
  • Eli Lilly secures exclusive worldwide rights for oral treatments identified by Insilico’s AI across multiple therapeutic areas.
  • Joint R&D programs will focus further on targets selected by Lilly.
• Quote:

  “Pharmaceutical giant Eli Lilly has struck a deal with Insilico to manufacture drugs discovered using the Hong Kong-listed company’s artificial intelligence model.”
  — Danny Lewis (00:54)

3. GM Boosts Heavy-Duty Truck Production Amid EV Interest

• Summary:
  Despite electric vehicle momentum, General Motors responds to strong demand for heavy-duty pickup trucks by increasing production.
• Production Details:
  • Starting June, the Flint, Michigan plant will operate six days a week
  • Output: over 1,000 Chevrolet Silverado and GMC Sierra trucks per day
• Customer Base:
  • Vehicles sold to both construction companies and individual customers.
• Quote:

  “General Motors plans to boost production of its most powerful pickup trucks. Starting in June, the automaker will run its heavy duty truck plant in Flint, Michigan, six days a week, citing strong customer demand.”
  — Danny Lewis (01:28)

4. Industry Shifts and Larger Implications

• Tech & Markets:
  • Tech startups are being recognized as quickly maturing market forces deserving fast-tracked equity index entry.
• Healthcare:
  • AI continues to make groundbreaking inroads into pharmaceutical R&D and production deals of unprecedented size.
• Auto Manufacturing:
  • Despite macro trends toward electrification, traditional vehicle segments can still command robust demand and large-scale manufacturing responses.

Notable Quotes & Timestamps

• 00:22: “Starting May 1st, NASDAQ listed companies will have the chance to quickly join its marquee NASDAQ 100 index instead of waiting up to a year.” — Danny Lewis
• 00:54: “Pharmaceutical giant Eli Lilly has struck a deal with Insilico to manufacture drugs discovered using the Hong Kong-listed company’s artificial intelligence model.” — Danny Lewis
• 01:28: “General Motors plans to boost production of its most powerful pickup trucks…citing strong customer demand.” — Danny Lewis

Timestamps for Key Segments

• 00:16 – 00:53: Nasdaq-100 fast entry for large tech companies
• 00:54 – 01:28: Eli Lilly & Insilico $2.75B AI drug development deal
• 01:29 – 02:03: GM expands heavy-duty truck production in response to demand

Memorable Moments

• The rapid shift for new tech darlings like OpenAI to gain index access, described as driven by direct lobbying from bankers.
• The scale of the Lilly-Insilico deal, underscoring the growing reliance on AI in core pharmaceuticals.
• GM’s confident doubling down on heavy-duty pickups, even as the EV market accelerates.

Episode Tone & Style

Brief, direct, and data-dense, capturing the momentum and competitive tension in rapidly evolving industries.

For more tech news updates, tune in every weekday to WSJ’s Tech News Briefing.